Recent News

• 07.24.2026 - Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
• 07.21.2026 - Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
• 06.15.2026 - Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis
• 03.31.2026 - CANOPY GROWTH UNVEILS NEW BRAND ‘DEELISH’: HIGH THC, EVERYDAY PRICE
• 03.30.2026 - CANOPY GROWTH’S APOLLO CANNABIS CLINICS NAMED BEST MEDICAL CANNABIS CLINIC
• 03.27.2026 - CANOPY GROWTH ANNOUNCES STORZ & BICKEL EXECUTIVE TRANSITION
• 03.16.2026 - Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada’s Leading Medical Cannabis Business By Revenue
• 02.18.2026 - Canopy Growth Announces MTL Cannabis Shareholder Approval of Acquisition
• 02.06.2026 - Canopy Growth Reports Third Quarter Fiscal 2026 Financial Results; Delivers double digit net revenue growth in Canada Cannabis contributing to a narrowing net loss; financial strength of $371M in cash and cash equivalents with a net cash position of $146M at December 31, 2025
• 01.23.2026 - Canopy Growth to Report Third Quarter Fiscal 2026 Financial Results on February 6, 2026

Recent Filings

• 07.17.2026 - PRE 14A Other preliminary proxy statements
• 06.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.22.2026 - 4 Statement of changes in beneficial ownership of securities